Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Acellular dermal matrix is a biologically derived product, which is devoid of cells. The main components of acellular dermal matrix include collagen and elastic fibers. In the recent past, there is a remarkable growth in application of acellular dermal matrices in plastic surgery, cosmetic surgery, breast reconstruction, and wound healing. Acellular dermal matrices were initially used  in the resurfacing of burn injuries, abdominal wall repair, tympanic membrane replacement, dural repairs, and gingival grafting.

The U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2,057.3 million in 2020 and is expected to exhibit a CAGR of 10.6% during the forecast period (2020-2027).

Figure 1.U.S. Acellular Dermal Matrices Market Share (%) in Terms of Value, By Origin 2020

U.S. Acellular Dermal Matrices  | Coherent Market Insights

The increasing product launch and approval is expected to drive the market growth during the forecast period.

Key players operating in the U.S. acellular dermal matrices market are focusing on launch and approval of technologically advanced acellular dermal matrices in the market, which is expected to drive the market growth over the forecast period. For instance, In April 2018, Musculoskeletal Transplant Foundation Biologics (MTF Biologics), a non-government organization, launched FlexHD Pliable PRE acellular dermal matrix that is designed especially for breast reconstruction procedures.

request-sample

U.S. Acellular Dermal Matrices Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 2,057.3 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 10.6% 2027 Value Projection: US$ 4,167.8 Mn
Geographies covered:
  • North America: U.S.
Segments covered:
  • By Origin: 
    • Human Dermis: Hospitals(In- patient, Out- patient), Ambulatory Surgical Centers, Office Based
    • Porcine Dermis: Hospitals(In- patient, Out- patient), Ambulatory Surgical Centers, Office Based
    • Bovine Dermis: Hospitals(In- patient, Out- patient), Ambulatory Surgical Centers, Office Based
  • By Application: 
    • Acute Wounds:(Burns, Trauma, Cancers, Infections)
    • Hospitals(In- patient, Out- patient), Ambulatory Surgical Centers, Office Based
    • Chronic Wounds:(Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcer, Others)
    • Hospitals(In- patient, Out- patient), Ambulatory Surgical Centers, Office Based
    • Reconstruction Procedures:(Abdominal Wall Procedures, Breast Procedures, Orthopedic Procedures, Others)
    • Hospitals(In- patient, Out- patient), Ambulatory Surgical Centers, Office Based
  • By Place of Setting: Hospitals(In- patient, Out- patient), Ambulatory Surgical Centers, Office Based
Companies covered:

Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.

Growth Drivers:
  • The rising number of surgeries
  • Increasing product launch and approval
Restraints & Challenges:
  • Complications of acellular dermal matrices in breast surgery and plastic surgery
  • Product recall

Figure 2 .U.S. Acellular Dermal Matrices Market Share (%), by Application, 2020

U.S. Acellular Dermal Matrices  | Coherent Market Insights

The rising number of surgeries are expected to drive expected to drive the market growth during the forecast period

Increased number of surgeries in the U.S. is expected to drive the growth of acellular dermal matrices market in the U.S. over the forecast period. For instance, according to the American Society of Plastic Surgeons 2019 report, around 265,209 liposuction surgeries were performed using acellular dermal matrices in 2019.

U.S. Acellular Dermal Matrices Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in more than 166 million infected individuals worldwide as of May 24th 2021.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. The pandemic had a major impact on the U.S., Japan, China, as well as other major European countries. Due to the increasing prevalence of COVID-19, key players operating in the U.S. acellular dermal matrices market are focusing on research and development of novel products to support and combat the effect of COVID-19. COVID-19 pandemic has impacted the global economy and, in turn, the U.S. Acellular Dermal Matrices Market. Quarantines, traveling constraints, and social distancing measures are likely to lead to a steep decline in business and consumer spending until the end of the third quarter of 2020.

U.S. Acellular Dermal Matrices Market: Restraint

The major factors that hinder the growth of the U.S. acellular dermal matrices market include complications of acellular dermal matrices in breast surgery and plastic surgery and product recall

Key Players

Major players operating in the U.S. Acellular dermal matrices market are Integra LifeSciences Corporation*, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.

Acellular dermal matrices are generated by decellularization process, which leads to the removal of the cells and preserving of the extracellular matrix. The extracellular matrix ones implanted in the required area, serves as the scaffold for the donor cells. The donor cells help in the revascularization, which in turn generates a new tissue. The main components of acellular dermal matrix include collagen and elastic fibers. Acellular dermal matrices are mostly used in breast surgery and plastic surgery. Seroma, infection, mastectomy skin necrosis, and expander/implant loss are the most commonly reported complications of acellular dermal matrices with respect to breast surgery.

Market Dynamics

The key player in the market focusing on adopting inorganic growth strategies such as acquisition and collaboration expected to drive the growth of acellular dermal matrices market over the forecast period. For instance, In December 2020, Integra Lifesciences Corporation acquired ACell, Inc., a U.S.-based biotechnology company. The acquisition helped Integra to expand its portfolio of acellular dermal matrix. Furthermore, In December 2019, Smith & Nephew Plc. Acquired Osiris Therapeutics Inc., a regenerative medicine company that offers skin, bone graft, and articular cartilage substitutes. The

acquisition helped Smith & Nephew Plc. To expand its product portfolio of acellular dermal matrix. Moreover, In April 2019, Cook Biotech, a biotechnological subsidiary of Cook Group, entered into a sales collaboration with Progressive Medical Inc., a U.S.-based medical products sales and marketing company. As a result of this sales collaboration, sales representatives employed by Progressive Medical would manage and support sales for the Cook Biotech Biodesign Hernia Graft in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the U.S. acellular dermal matrices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S. acellular dermal matrices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • U.S. acellular dermal matrices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing U.S. acellular dermal matrices market

Detailed Segmentation:

  • U.S. Acellular Dermal Matrices Market, By Origin:
    • Human Dermis
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Porcine Dermis
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Bovine Dermis
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
  • U.S. Acellular Dermal Matrices Market, By Application:
      • Acute Wounds
        • Burns
        • Trauma
        • Cancers
        • Infections
      • Hospitals     
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Chronic Wounds
        • Diabetic Foot Ulcers
        • Venous Leg Ulcers
        • Pressure Ulcer
        • Others
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Reconstruction Procedures
        • Abdominal Wall Procedures
        • Breast Procedures
        • Orthopedic Procedures
        • Others
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
  • U.S. Acellular Dermal Matrices Market, By  Place of Setting
    • Hospitals
      • In- patient
      • Out- patient
    • Ambulatory Surgical Centers
    • Office Based
  • Company Profiles
    • Integra LifeSciences Corporation*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Abbvie Inc.
    • Johnson & Johnson
    • HansBioMed
    • Becton, Dickinson and Company
    • Cook Group
    • Smith & Nephew Plc.
    • Reprise Biomedical
    • Organogenesis Holdings Inc.
    • Tissue Regenix
    • LifeNet Health
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • MiMedx Group
    • PolyNovo Limited
    • Fidia Pharma USA Inc.
    • Baxter International Inc.
    • In2Bones Global
    • BioHorizons, Inc.
    • Harbor MedTech, Inc.
    • MLM Biologics Inc.
    • Geistlich Pharma AG
    • Olaregen Therapeutix, Inc
    • EnColl Corporation
    • Kerecis limited
    • DSM
    • ACell Inc.
    • 3M
    • Cell Constructs I, LLC
    • Marine Polymer Technologies, Inc.

‘*’ marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Origin
      • Market Snapshot, By Application
      • Market Snapshot, By Place of Setting
    • Coherent Market Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
    • Impact Analysis
    • Regulatory Scenario
    • PEST Analysis
    • Key Developments
    • Technological Advancement
    • New Product Launch/Approvals
    • Acquisition, Collaboration & Agreements
    • Market Share Analysis
    • Brand Analysis
  4. U.S. Acellular Dermal Matrices Market– Impact of Coronavirus (COVID-19) Pandemic
    • Impact on Supply and Demand
    • Impact on Procedures
    • Government Initiatives
  5. U.S. Acellular Dermal Matrices Market, By Origin, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Human Dermis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Porcine Dermis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Bovine Dermis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
  6. U.S. Acellular Dermal Matrices Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Acute Wounds
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Burns
        • Trauma
        • Cancers
        • Infections
      • Hospitals     
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Chronic Wounds
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Diabetic Foot Ulcers
        • Venous Leg Ulcers
        • Pressure Ulcer
        • Others
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
    • Reconstruction Procedures
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Abdominal Wall Procedures
        • Breast Procedures
        • Orthopedic Procedures
        • Others
      • Hospitals
        • In- patient
        • Out- patient
      • Ambulatory Surgical Centers
      • Office Based
  7. U.S. Acellular Dermal Matrices Market, By Place of Setting, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • In- patient
        • Out- patient
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Office Based
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Integra LifeSciences Corporation*
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • AbbVie Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Johnson & Johnson
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • HansBioMed
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Becton, Dickinson and Company
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Cook Group
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Smith & Nephew Plc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Reprise Biomedical
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Organogenesis Holdings Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Tissue Regenix
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • LifeNet Health
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Zimmer Biomet Holdings, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Stryker Corporation
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • MiMedx Group
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • PolyNovo Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Fidia Pharma USA Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Baxter International Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • In2Bones Global
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • BioHorizons, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Harbor MedTech, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • MLM Biologics Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Geistlich Pharma AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Olaregen Therapeutix, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • EnColl Corporation
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Kerecis limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • DSM
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • ACell Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • 3M
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Cell Constructs I, LLC
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Marine Polymer Technologies, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
    • Analyst Views
  9. Section
    • Research Methodology
    • About us

*Browse 9 market data tables and 17 figures on ‘U.S. Acellular Dermal Matrices Market’ - Global forecast to 2027

FAQgrowicon

Frequently Asked Questions

The U.S. acellular dermal matrices market size is estimated to be valued at US$ 2,057.3 million in 2020 and is expected to exhibit a CAGR of 10.6% between 2020 and 2027.
Factors such as the rising number of surgeries and increasing product launch and approval are expected to drive the market growth during the forecast period.
Human Dermis segment is expected to hold a major market share owing to increasing product approvals and launches during the forecast period.
The major factors hampering the growth of the market include complications of acellular dermal matrices in breast surgery and plastic surgery and product recall.
Major players operating in the market are Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner